|
Friday, June 8 |
|
6:00 PM |
Conference Registration |
|
|
8:00 PM |
Welcome Reception and Dinner |
|
|
Saturday, June 9 |
|
7:30 AM |
Breakfast |
|
|
8:30 AM |
Welcome & Opening Remarks |
|
|
SESSION I |
Tumor Immunology and Immunotherapy I Chair: Costas Koumenis |
|
|
Keynote Speaker |
||
|
8:35 AM |
1 |
Immunogenic therapies targeting specific organelles or molecules within cancer cells Guido Kroemer |
|
9:30 AM |
2 |
Inactivation of the type I interferon responses in the tumor microenvironment engenders the immune privileged niche and desmoplasia Serge Fuchs |
|
9:55 AM |
3 |
ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells promotes metastasis in triple negative breast cancer Rumela Chakrabarti and Sushil Kumar |
|
10:20 AM |
4 |
Targeting Immune Evasion in Cancer to Improve Radiation Sensitivity Todd Aguilera, Amato Giaccia, Hussein Shehade, Marjan Rafat, Laura Castenelli, Lesley Ellies, Edward Graves, and Eslam Elghonaimy |
|
10:30 AM |
Coffee Break and Poster Viewing |
|
|
SESSION II |
Tumor Immunology and Immunotherapy II Chair: Ravi Amaravadi |
|
|
11:15 AM |
5 |
Targeting the innate immune response in brain metastasis Nicola Sibson |
|
11:40 AM |
6 |
Radiation as an immunomodulatory drug Chandan Guha |
|
12:05 PM |
7 |
Using radiation to augment the effects of immunomodulatory agents Amit Maity |
|
12:30 PM |
8 |
“Instituting Molecular Precision in Localised Prostate Cancer - Marrying the Tumor Micro-environment to Genomics” Robert Bristow |
|
SESSION III |
Oncogenic stress, tumor metabolism and targeting metabolic vulnerabilities Chair: Ester Hammond |
|
|
12:55 PM |
9 |
How and Why Ras and Myc cooperate Gerard Evan, Trevor Littlewood, Nicole Sodir, Roderik Kortlever, Luca Pellegrinet, and Tania Campos |
|
1:20 PM |
10 |
MYC, lipid metabolism and calcium signaling in breast cancer Zachary Schug |
|
1:45 PM |
11 |
Targeting the metabolic vulnerability of metastatic cancer Jiangbin Ye |
|
2:00 PM |
Lunch and Informal Discussions |
|
|
7:30 PM |
Dinner and Informal Discussions |
|
|
Sunday, June 10 |
|
7:30 AM |
Breakfast |
|
|
SESSION IV |
Stress resistance & cancer: Targeting organelle-specific stress responses Chair: Eric Chevet |
|
|
Keynote Speaker |
||
|
8:30 AM |
12 |
Targeting LAP: LC3-associated phagocytosis and anti-cancer immunity Douglas Green |
|
9:25 AM |
13 |
Leveraging the mechanism of autophagy regulation of tumor cell apoptosis to improve cancer therapies Andrew Thorburn |
|
9:50 AM |
14 |
RIPK1-mediated induction of mitophagy compromises the viability of extracellular-matrix-detached cells. Zachary Schafer |
|
10:15 AM |
15 |
ER translocation of the entire MAPK pathway is required for ERK reactivation and autophagy, driving therapy resistance in BRAF mutant cancers Rani Ojha , Nektaria Leli , Angelique Onorati , Ioannis Verginadis, Shengfu Piao , Feven Tameire, Cynthia Chude , Costas Koumenis, and Ravi Amaravadi |
|
10:40 AM |
16 |
Critical role of Beclin 2 in innate immune signaling and tumor development through non-canonical autophagy and metabolic pathways Helen Yicheng Wang |
|
10:50 AM |
Coffee Break and Poster Viewing |
|
|
SESSION V |
Tumor stroma and impact on tumor response to treatment Chair: J. Alan Diehl |
|
|
11:35 AM |
17 |
Exploiting the Biology of Tumor Stroma and Exosomes for Diagnosis and Treatment of Cancer Raghu Kalluri |
|
12:00 PM |
18 |
Shifting Fibroblasts between Catabolism and Anabolism through Metabolic Regulation Governs Extracellular Matrix Homeostasis Xiao Zhao, Laleh Soltan-Ghoraie, Pamela Psarianos, Kenneth Yip, David Goldstein, Ralph Gilbert, Ian Witterick, Hilary Pang, Ali Hussain, Ju Hee Lee, Justin Williams, Scott Bratman, Laurie Ailles, Benjamin Haibe-Kains, and Fei-Fei Liu |
|
12:25 PM |
19 |
Lung Endothelial Cells Promote Epithelial to Mesenchymal Transition Sandra Ryeom |
|
12:50 PM |
20 |
Molecular imaging of an oncoprotein in tumor ECM for cancer detection and risk-stratification Zheng-Rong Lu |
|
1:00 PM |
Lunch and Informal Discussions |
|
|
SESSION VI |
Radiotherapy, the TME & metastasis Chair: Albert Koong |
|
|
3:00 PM |
21 |
A novel small molecule inhibitor of MRCK prevents radiation driven invasion of glioblastoma cells and extends survival in an orthotopic xenograft model Anthony Chalmers, Joanna Birch, Lesley Gilmour, Laura McDonald, Justin Bower, Heather McKinnon, Mari Sime, and Michael Olson |
|
3:25 PM |
22 |
Assessment of metastasis targeting agents in the laboratory and the clinic Veronica Hughes and Dietmar Siemann |
|
3:50 PM |
23 |
Polyamine-mediated epigenetic gene regulation and radiation response in glioblastoma. Scott Welford |
|
7:30 PM |
Dinner and Informal Discussions |
|
|
Monday, June 11 |
|
7:30 AM |
Breakfast |
|
|
SESSION VII |
The Unfolded Protein Response and Integrated Stress Response in cancer I Chair: Andrew Thorburn |
|
|
8:30 AM |
24 |
Escape of endoplasmic reticulum chaperones to the cell surface: mechanisms and consequences Amy Lee, Yuan-Li Tsai, Dat Ha, and Anthony Carlos |
|
8:55 AM |
25 |
Mapping the functional interplay between PERK and Sphingolipids J. Alan Diehl and Dariusz Pytel |
|
9:20 AM |
26 |
The ISR effector ATF4 is a critical regulator of Myc-dependent translational program and tumorigenesis Costas Koumenis |
|
9:45 AM |
27 |
Protein synthesis in cancer: when too much of a good thing is bad Davide Rugerro |
|
10:10 AM |
28 |
PKR-dependent eIF2α serine 51 phosphorylation suppresses HER2-mediated breast tumorigenesis and increases the potency of Trastuzumab therapy. Cedric Darini, Shuo Wang, Catherine Chabot, Gloria Assaker, Jothilala Krishnamoorthy, Siham Sabri, Giuseppina Ursini-Siegel, Mark Basik, and Antonis Koromilas |
|
10:35 AM |
29 |
A critical role for the ISR effector ATF4 in the tumor stroma in primary and metastatic tumor growth Ioannis Verginadis, Brett Bell, Sravya Koduri, Nektaria Maria Leli, Frank Chinga, and Constantinos Koumenis |
|
10:45 AM |
Coffee Break and Poster Viewing |
|
|
SESSION VIII |
The Unfolded Protein Response and Integrated Stress Response II Chair: Serge Fuchs |
|
|
11:30 AM |
30 |
Complexity of IRE1 signaling in tumor development and therapeutic opportunities Eric Chevet |
|
11:55 AM |
31 |
Targeting IRE1alpha/XBP1 for Promoting Immunogenic Cell Death in Triple-Negative Breast Cancer Treatment Chih-Chien Chou, Dadi Jiang, Zhifen Yang, and Albert Koong |
|
12:20 PM |
32 |
Activation of a Major Arm of the UPR Proteotoxic Stress Response by Lipid Signaling Arvin Tam, Lindsay Roberts, Daniel Nomura, and Maho Niwa |
|
12:45 PM |
33 |
IRE1 as a potential therapeutic target in cancer Afshin Samali |
|
1:10 PM |
34 |
Translational regulation of stem cell factors underpins the stress-induced plasticity of breast cancer cells Lynne-Marie Postovit, Michael Jewer, Laura Lee, Scott Findlay, Guihua Zhang, and Jiahui Liu |
|
1:20 PM |
35 |
Targeting IRE1alpha/XBP1 for Promoting Immunogenic Cell Death in Triple-Negative Breast Cancer Treatment Chih-Chien Chou, Dadi Jiang, Zhifen Yang, and Albert Koong |
|
1:30 PM |
Lunch and Informal Discussions |
|
|
3:30 PM |
City Tour |
|
|
7:30 PM |
Dinner and Informal Discussions |
|
|
Tuesday, June 12 |
|
7:30 AM |
Breakfast |
|
|
SESSION IX |
Tumor hypoxia- Impact on tumor progression Chair: Amit Maity |
|
|
8:30 AM |
36 |
Understanding and exploiting the hypoxia-induced DNA damage response Ester Hammond |
|
8:55 AM |
37 |
Hypoxic Tumor Microenvironment, Tumor Cell Fate Regulation, and Therapy Response Qun Lin, Hoon Kim, Peter Glazer, and Zhong Yun |
|
9:20 AM |
38 |
Metabolic adaptation of VHL-deficient and/or HIF-expressing cancer cells to glutamine deprivation. Danos Christodoulou, Evmorfia Konstantakou, Junyoung Park, Tianjin Yi, Ravi Sundaram, Gregory Stephanopoulos, Lee Zou, and Othon Iliopoulos |
|
9:45 AM |
39 |
Microenvironmental inhibition of triglyceride hydrolysis supports tumor growth Matthew VandeKopple, Soumen Karmahapatra, Jinghai Wu, and Ioanna Papandreou |
|
10:10 AM |
40 |
Hypoxia-mediated repression of the DDX5 RNA helicase - a crucial factor in DNA replication of cancer cells Katarzyna Leszczynska and Ester Hammond |
|
10:20 AM |
41 |
Repurposing papaverine as a metabolic radiosensitizer Nic Denko |
|
SESSION X |
Meet the experts Chairs: Alexia-Ileana Zaromytidou |
|
|
10:30 AM |
42 |
NIH grant system and NCI Division of Cancer Biology Konstantin Salnikow |
|
11:00 AM |
43 |
Reproducibility in basic and translational research Alexia-Ileana Zaromytidou |
|
11:30 AM |
Coffee Break and Poster Viewing |
|
|
SESSION XI |
Clinical-Therapeutic implications Chair: Fei-Fei Liu |
|
|
12:15 PM |
44 |
Proton Radiation in the setting of combined modality therapy James Metz |
|
12:40 PM |
45 |
Hypoxia imaging: HX4 and Radiomics, the “rich” vs “poor” man approaches – Towards multifactorial predictive algorithms Philippe Lambin, Sebastian Sanduleanu, Henry Woodruff, Ala Yaromina, Jan Theys, Ludwig Dubois, and Arthur Jochems |
|
1:05 PM |
46 |
Improving radiotherapy by targeting hypoxia: will it ever become routine clinical practice Michael Horsman |
|
1:30 PM |
47 |
Discovery of the plasma membrane reductase responsible for the activation of the cell-excluded hypoxia-activated prodrug Tarloxotinib Shevan Silva, Chris Guise, Matt Bull, Cris Print, Jeff Smaill, and Adam Patterson |
|
1:40 PM |
Closing Remarks |
|
|
1:45 PM |
Lunch and Informal Discussions |
|
|
8:00 PM |
Farewell Dinner |
|
|
Wednesday, June 13 |
|
8:00 AM |
Breakfast |
|
|
10:00 AM |
Departure |
|
POSTERS |
|
48 |
Improving treatment decisions in colon cancer. The tumor-stroma ratio (TSR) additional to the TNM classification Wilma Mesker |
|
49 |
TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1a stabilization Nami McCarty |
|
50 |
Identification of functionally distinct subtypes of cancer-associated fibroblasts in high grade serous ovarian cancer and their impact on survival Ali Hussain, Veronique Voisin, Stephanie Poon, Jalna Meens, Gary Bader, Benjamin Neel, and Laurie Ailles |
|
51 |
Identifying compensatory responses to autophagy inhibition in autophagy-dependent cancer cells Christina Towers, Michael Morgan, and Andrew Thorburn |
|
52 |
Synthetic lethal screens to identify treatments for CREB3L1-deficient breast cancers Deborah Anderson, Paul Mellor, Shari Smith, Stephanie Kendall, and Dielle Whitecross |
|
53 |
Novel roles of the endocytic protein Rab5 in hypoxia-dependent tumor cell migration, invasion and metastasis Patricio Silva, Solange Rivas, Pablo Mendoza, Jorge Diaz, and Vicente Torres |
|
54 |
MicroRNA-21 inhibitor potentiates anti-tumor effect of radiation therapy in vitro and in vivo David Lee, Hans Kim, Bong Cho, Yeo Hyun Hwang, and In Ah Kim |
|
55 |
A Radiosensitivity Gene Signature and PD-L1 Status Predict Clinical Outcome of Patients with Glioblastoma Bum Sup Jang and In Ah Kim |
|
56 |
Response to Stress by the Tumor Microenvrionment Kerry Roby, Bang-Jin Kim, Allyson Lieberman, Minhyeong Kim, Sandra Ryeom, Donita Brady, and Costas Koumenis |
|
57 |
WSB1 regulation of DNA repair in the tumour microenvironment: a novel 'BRCAness' marker? Merce Gomez-Merchan, Flore-Anne Poujade, Patrícia Grácio, and Isabel Pires |
|
58 |
Radiosensitization capacities of a novel estradiol analogue assessed on a bone metastasis model Jolene Helena |
|
59 |
Cathepsin L and K inhibition by small molecule KGP94 suppresses pulmonary metastasis in murine osteosarcoma Henrietta Fasanya , Christine Pampo, Lori Rice , and Dietmar Siemann |
|
60 |
Effects of Exercise on the Breast Tumor Microenvironment in hyperlipidemic Mice Linda Buss, Margaret Currie, Abel Ang, and Gabi Dachs |
|
61 |
Vitamin C administration in colorectal cancer patients: a clinical trial aimed at determining biological efficacy Gabi Dachs, Jamish Gandhi, Helen Morrin, Christina Wohlrab, Simone Bayer, Anitra Carr, Timothy Eglinton, Bridget Robinson, and Margreet Vissers |
|
62 |
CP-506, a next generation hypoxia-activated prodrug, as a promising novel anti-cancer therapeutic Sofie Deschoemaeker, Sophie Thiolloy, Julie Gilissen, Ludwig Dubois, Ala Yaromina, Jan Theys, Amir Ashoorzadeh, Chris Guise, Maria Abbattista, Mathew Bull, Jeff Smaill, Adam Patterson, Philippe Lambin, and Arne Heyerick |
|
63 |
Ovarian cancer cell lines grown in a three dimensional collagen model respond differentially to Lysophosphatidic acid and Tumour Necrosis Factor-alpha. Alexandria Tino, Gabi Dachs, Peter Sykes, John Evans, and Kenny Chitcholtan |
|
64 |
Divergent roles of fibroblasts on the radiation-response of cancer cells Alizée Steer, Sara Sofia Deville, Nils Cordes, Verena Jendrossek, and Diana Klein |
|
65 |
PPT1 promotes tumor growth and is the molecular target of chloroquine-derivatives in cancer Cynthia Chude, Vito Rebecca, Michael Nicastri, Colin Fennelly, Julie Barber-Rotenberg, Rani Ojha, Amruta Ronghe, Quentin McAfee, Noel McLaughlin, Gao Zhang, Shengfu Piao, Phyllis Gimotty, Meenhard Herlyn, Xiaowei Xiao, Ronen Marrmorstein, David Speicher, Jeffrey Winkler, and Ravi Amaravadi |
|
66 |
Hypoxia tumour targeting with Tarloxotinib to improve clinical outcomes for patients with EGFR-dependent malignancies Victoria Jackson-Patel, Kevin Hicks, Shevan Silva, Christopher Guise, Matthew Bull, Maria Abbattista, Amir Ashoorzadeh, Jeff Smaill, and Adam Patterson |
|
67 |
Distinct immune status in patients with adenocarcinoma and squamous cell carcinoma: implication for immunotherapy of non-small cell lung cancer Irena Adkins, Nada Hradilova, Ondrej Palata, Lenka Sadilkova, Lenka Palova Jelinkova, Klara Danova, Dagmar Mysikova, Robert Lischke, and Radek Spisek |
|
68 |
Inactivation of type I interferon signaling by tumor-derived factors promotes the generation of the pre-metastatic niche in the lungs Jun Gui, Farima Zahedi, and Serge Fuchs |
|
69 |
Axl signaling under hypoxia persists in the absence of its ligand Gas6 Mai Tanakaand Dietmar Siemann |
|
70 |
The role of cathepsin L in macrophage-driven breast cancer progression and dissemination Samantha Dykes and Dietmar Siemann |
|
71 |
Diet impacts mammary gland unfolded protein response signaling and mitochondrial metabolism to modulate breast tumorigenesis David Soto-Pantoja, Adam Wilson, and Katherine Cook |
|
72 |
Design, discovery and preclinical antitumour activity of SN38080, a novel hypoxia-activated irreversible FGFR1-3 inhibitor Jeff Smaill, Amir Ashoorzadeh, Xueqiang Li, Christopher Guise, Maria Abbattista, Angus Grey, Matthew Bull, Swarna Gamage, Maria Kaliukina, Yuliana Yosaatmadja, Rana Taghipouran, Huai-Ling Hsu, Woo-Kyong Paik, Jinfeng Luo, Shuang Jiang, Zheng-Chao Tu, Yong Xu, Robert Anderson, Xiaomei Ren, Christopher Squire, Ke Ding, and Adam Patterson |
|
73 |
Ovarian cancer stem cells are maintained by fibroblastic niche and have constitutively active stress-response signaling. TOSHIHIKO TORIGOE, YOSHIHIKO HIROHASHI, KAZUYO YASUDA, and TSUYOSHI SAITO |
|
74 |
Innate immune signaling regulates microbiota, immune infiltrates and tumor development in a TAK1-deficient mouse model Rongfu Wang |
|
75 |
ΔNp73 enhances HIF-1α protein stability through repression of the ECV complex. Marina Stantic, Johanna Wolfsberger, Habib Sakil, and Margareta Wilhelm |
|
76 |
The role of Lcn-2 in determining the macrophage iron phenotype and its impact on cancer progression Michaela Jung, Christina Mertens, Claudia Rehwald, Matthias Schnetz, and Bernhard Brüne |
|
77 |
Translational and HIF1alpha -dependent metabolic reprograming underpin oncometabolome plasticity. Ivan Topisirovic |
|
78 |
SCF/CD117 signaling axis drives prostate cancer aggressiveness and metastasis Bethany Kerr, Lihong Shi, Koran Harris, Brittni Foster, Aleksander Skardal, and Mary Mobley |
|
79 |
Deficiency of CD47 regulates metabolism and hypoxia in the tumor microenvironment Katherine Cook, Tiffany Newman, Adam Wilson, Yismeilin Feliz-Mosquea, Elizabeth Stirling , Lilya Yamaleyeva, and David Soto Soto-Pantoja |
|
80 |
Angiotensin-(1-7) reduces pediatric sarcoma growth through regulation of tumor cell proliferation and angiogenesis Patricia Gallagher and E. Ann Tallant |
|
81 |
Prevention of Breast Tumor Growth by a Muscadine Grape Extract through Alteration of the Tumor Microenvironment E. Ann Tallant and Patricia Gallagher |
|
82 |
Prevention of Breast Tumor Growth by a Muscadine Grape Extract through Alteration of the Tumor Microenvironment E. Ann Tallant and Patricia Gallagher |
|
83 |
Hypoxia-mediated regulation of APOBEC expression Sam Bader and Ester Hammond |
|
84 |
Identifying novel regulators of UPR by utilizing genome-scale CRISPR-Cas9 knockout screens Nektaria Maria Leli, Souvik Dey, Lauren Brady, Ioannis Verginadis, Carlo Salas Salinas, and Constantinos Koumenis |
|
85 |
The identification of a new subtype of myeloid cells in tumor microenvironment by lineage-tracing. Oleg DEMIDOV, Bogdan Grigorash, Burhan Uyanik, Elena Kochetkova, Evgeniy Eruslanov, and Ettore Appella |
|
86 |
Targeting IRE1alpha/XBP1 for Triple-Negative Breast Cancer Therapy Dadi Jiang, Zhifen Yang, Chih-Chien Chou, Rakesh Bam, and Albert Koong |
|
87 |
GAS6/AXL signaling mediates hypoxia-induced epithelial-mesenchymal transition and invasiveness in hepatocellular carcinoma Anne Ernst |
|
88 |
Molecular Analysis of Hemangioblastoma tumors of the Central Nervous System Eumorphia Konstantakou, Ana Metelo, Nicholas Haradhvala, Atanas Kamburov, Jean-Valery Coumans, Frederick Barker, Brian Nahed, Anat Stemmer-Rachamimov, Gad Getz, and Othon Iliopoulos |
|
89 |
Stress signaling in breast cancer cells induces matrix components of stem cell niches that promote chemotherapy-resistant metastasis Jacob Insua-Rodríguez, Maren Pein, Tsunaki Hongu, Jasmin Meier, Arnaud Descot, Camille Lowy, Etienne De Braekeleer, Hans-Peter Sinn, Saskia Spaich, Marc Sütterlin, Andreas Schneeweiss, and Thordur Oskarsson |
|
90 |
TAp73 loss results in elevated levels of CCL2 and higher macrophage infiltration into the tumor microenvironment Johanna Wolfsberger, Habib Sakil, Marina Stantic, Margareta Wilhelm, Tatjana Wallmann, and Charlotte Rolny |
|
91 |
Pyruvate dehydrogenase kinase 1 (PDHK1) and carbonic anhydrase IX (CAIX) regulation and targeting in hypoxic tumors Martin Kery, Silvia Radenkovic, Nina Oravcova, Maria Bartosova, and Tereza Golias |
|
92 |
Molecular basis of transient therapy resistance in colorectal cancer liver metastasis Theodora Fifis, Linh Nguyen, George Kastrappis, and Christopher Christophi |
|
93 |
Intra- and extracellular signalling pathways activated in cancer cells by microtubule disruptors structurally modified to bind preferentially to carbonic anhydrase IX Anne Mercier, Laurence Lafanechère, Michael Pepper, and Annie Joubert |
|
94 |
The role of neuropilin-1 and VEGF isoforms and their potential as predictive biomarkers of response to vascular-targeted therapies Ruth Thomas, Chryso Kanthou, William English, and Gillian Tozer |
|
95 |
Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation Yongjoon Suh, Ki-Chun Yoo, Mi-Young Choi, and Su-Jae Lee |
|
96 |
Inhibiting C5a-C5aR pathway to improve radiation response Monica Olcina, Stavros Melemenidis, Ryan Kim, Edward Graves, and Amato Giaccia |
|
97 |
Intercellular communication of tumour cells and macrophages drives tumour cell migration and immunosuppression Annamaria Gal, Dammar Thapa, Thaneswari Karpanasamy, and Chelsea Street |
|
98 |
Chloroquine or autophagy inhibition in endothelial cells distinctly reshape intercellular signaling in the tumor vasculature Marco Schaaf, Diede Houbaert, Hannelore Maes, Odeta Mece, San Kit To, and Patrizia Agostinis |
|
99 |
force-mediated proinvasive matrix remodeling driven by tumor-associated mesenchymal stem-like cells in glioblastoma Jae-Hyeok Kang, Eun-Jung Lim, Yongjoon Suh, Seungmo Kim, and Su-Jae Lee |
|
100 |
Investigating the role of radiation in tumor cell recruitment to the lungs Luis Soto, Stavros Melemenidis, and Edward Graves |
|
101 |
Migrastatics—anti-metastatic and anti-invasion drugs: promises and challenges Aneta Gandalovičová, Daniel Rosel, Michael Fernandes, Pavel Veselý, Victoria Sanz Moreno, and Jan Brábek |
|
102 |
Quantitative phase imaging as a tool for analyzes of cancer cell invasion Ondrej Tolde, Aneta Gandalovicova, Aneta Krizova, Pavel Vesely, Radim Chmelik, Jan Brabek, and Daniel Rosel |
|
103 |
Foxn1 expression in keratinocytes is stimulated by hypoxia: further evidence of its role in skin wound healing Anna Kur-Piotrowska, Joanna Bukowska, Marta Kopcewicz, Mariola Dietrich, Joanna Nynca, Mariola Slowinska, and Barbara Gawronska-Kozak |
|
104 |
Cancer Invasion in Organ-Specific ExtraCellular Matrices Ninna Rossen |